Skip to main content

L088 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint L088 is White, Elliptical / Oval and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L088

Divalproex Sodium Extended-Release

Imprint
L088
Strength
250 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
68180-0260

Get help with Imprint Code FAQs.

Related Images for "L088"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.